1. Home
  2. MAMA vs VYGR Comparison

MAMA vs VYGR Comparison

Compare MAMA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

HOLD

Current Price

$14.51

Market Cap

649.2M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.84

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAMA
VYGR
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
649.2M
236.0M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
MAMA
VYGR
Price
$14.51
$3.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$19.00
$16.50
AVG Volume (30 Days)
360.5K
542.3K
Earning Date
04-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
44.44
N/A
EPS
0.13
N/A
Revenue
$95,420,129.00
$10,135,000.00
Revenue This Year
$31.09
$34.04
Revenue Next Year
$16.12
$7.92
P/E Ratio
$107.42
N/A
Revenue Growth
95.54
N/A
52 Week Low
$6.19
$2.65
52 Week High
$17.85
$5.55

Technical Indicators

Market Signals
Indicator
MAMA
VYGR
Relative Strength Index (RSI) 43.55 44.01
Support Level $14.43 $3.72
Resistance Level $14.92 $3.85
Average True Range (ATR) 0.76 0.19
MACD -0.12 0.00
Stochastic Oscillator 27.64 24.06

Price Performance

Historical Comparison
MAMA
VYGR

About MAMA Mama's Creations Inc.

Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: